Publicacións en colaboración con investigadores/as de Hospital Universitario de Valladolid (25)

2025

  1. Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry

    International Journal of Cardiology, Vol. 419

2024

  1. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  2. Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

    International Journal of Cardiology, Vol. 405

2023

  1. Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246

  2. The current clinical practice for management of post-infarction ventricular septal rupture: a European survey

    European Heart Journal Open, Vol. 3, Núm. 5

2022

  1. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

    Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136

  2. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry

    Journal of the American Heart Association, Vol. 11, Núm. 13

  3. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

  4. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  5. Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278

  6. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  7. Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort

    International Journal of Cardiology, Vol. 367, pp. 90-98

2021

  1. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

    Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633

  2. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  3. Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart

    Clinical and Experimental Medicine, Vol. 21, Núm. 2, pp. 249-268

  4. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19

    Age and ageing, Vol. 50, Núm. 2, pp. 326-334

  5. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

    Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280

  6. Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis

    BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292

  7. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  8. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry

    Emergency Medicine Journal, Vol. 38, Núm. 5, pp. 359-365